Low-Dose Amikacin for Multidrug-Resistant Tuberculosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMC Infectious Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Low-Dose Amikacin in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)
BMC Infect. Dis 2021 Mar 10;21(1)254, NF Sabur, MS Brar, L Wu, SK BrodeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.